Accendra Health
266 hedge funds and large institutions have $3.39B invested in Accendra Health in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 89 increasing their positions, 103 reducing their positions, and 35 closing their positions.
27% more call options, than puts
Call options by funds: $12.8M | Put options by funds: $10.1M
9% more capital invested
Capital invested by funds: $3.11B → $3.39B (+$278M)
4.81% more ownership
Funds ownership: 95.69% → 100.5% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 35
2% less funds holding
Funds holding: 272 → 266 (-6)
14% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 103
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$282M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$23.4M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$20M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$19.5M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$55.1M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$27.5M |
| 3 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
-$22.7M |
| 4 |
Millennium Management
New York
|
-$15.4M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.06M |
ACH Hedge Fund Activity: Q1 2022 in Review
266 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q1 2022, worth a combined $3.39B — up 8.9% from $3.11B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of ACH and 34 opened new positions — a net loss of 1 holder — while 103 trimmed existing stakes and 89 added.
The largest buyer was Fidelity Investments, adding an estimated $282M. The largest seller was Citadel Advisors, cutting an estimated $55.1M.
- 266 institutional investors held Accendra Health (ACH) as of Q1 2022, down from 272 in Q4 2021.
- Funds reported $3.39B of Accendra Health stock for Q1 2022, up 8.9% quarter-over-quarter.
- 34 funds opened new Accendra Health positions in Q1 2022 and 35 closed out, a net change of -1 holder.
- The largest Accendra Health buyer in Q1 2022 was Fidelity Investments, an estimated $282M added.
- The largest Accendra Health seller in Q1 2022 was Citadel Advisors, an estimated $55.1M sold.
Based on aggregated 13F filings for Q1 2022.